Product information and disease descriptionProduct descriptionProduct information
Average sales price and wholesale acquisition cost
2 evidence topics · 1 source
Summary
The sponsor describes a potential annual pricing range of approximately $100,000 to $200,000 per patient. The cited presentation does not identify this range as an established ASP or WAC.
Established average sales price and wholesale acquisition cost
No evidence found.